Q2 FY2026 · ended Jun 30, 2026 · Revenue $2.07M, +113.4% YoY · Filed Aug 14, 2026
Healthy Extracts Inc. (HYEX) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.1 million and a net loss of $129,389. As of Jun 30, 2026 it held $189,958 in cash and investments and $425,925 in total debt.
Revenue
$2.07M
+113.4% vs year-ago quarter
Net income
$-129,389
-292.8% vs year-ago quarter
Operating cash flow
$306,013
+1677.6% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
14.74M
-12.6% vs year-ago quarter
Net cash
$-235,967
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- HYEX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1630176
- Former names
- HEALTHLY EXTRACTS INC. (until Mar 11, 2021); GREY CLOAK TECH INC. (until Feb 19, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1M | $1.6M | $1.7M | $917,975 | $968,656 |
| Net income | -$129,389 | -$200,590 | -$153,986 | -$395,394 | $67,120 |
| Operating cash flow | $306,013 | $105,970 | $368,154 | -$279,870 | $17,215 |
| Total assets | $32.6M | $27.3M | $27.8M | $26.2M | $2.5M |
| Total liabilities | $10.2M | $3.3M | $3.8M | $2.1M | $2.0M |
| Stockholders' equity | $22.4M | $24.0M | $24.0M | $24.1M | $477,958 |
| Cash and investments | $189,958 | $164,385 | $146,935 | $23.7M | $200,495 |
| Total debt | $425,925 | $471,553 | $516,195 | $167,734 | $181,841 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 18, 2026 | Sep 13, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 24, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change
|
May 18, 2026 | May 15, 2026 |
All 195 Healthy Extracts Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.